FDA issues complete response letter to Replimune’s RP1 for melanoma
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Replimune Group’s biologics licence application…
Oncology
-
-
BioNTech and DualityBio report positive data for trastuzumab pamirtecan
BioNTech and DualityBio reported encouraging data from a Phase II cohort of their global clinical study evaluating the efficacy of…
-
North Oaks opens new speciality services clinic in US
The North Oaks Health System has opened a new $50m, five-storey speciality services clinic in Hammond, Louisiana, US. The new…
-
New £1bn cancer research hub planned for South London
Plans have been unveiled for The London Cancer Hub, a state-of-the-art cancer research and laboratory hub to be located in…
-
NCCN visits Vietnam in continued cancer care collaboration
Leaders from the National Comprehensive Cancer Network (NCCN) alliance of US cancer centres are in Vietnam today (1 November) as…
-
The Oncology Institute announces chief financial officer transition
The Oncology Institute (TOI) has revealed a significant change in its executive team, announcing the upcoming departure of chief financial…
-
Ground broken on St Joseph’s Hospital’s new proton therapy centre in Florida
Construction of the first proton therapy facility at the BayCare Cancer Institute at St Joseph's Hospital in the Tampa Bay…
-
Mount Sinai launches new gynaecologic cancer centre
Mount Sinai Health System has announced the opening of its Center of Excellence for Gynaecologic Cancer in the US. The new…
-
DIB to provide $4.08m to support development of cancer care hospital in Dubai
The UAE-based Dubai Islamic Bank (DIB) has pledged to provide around AED15m ($4.08m) to the Al Jalila Foundation to support the…
-
City of Hope appoints new EVP and technology officer
US-based cancer research and treatment organisation City of Hope has announced the appointment of Simon Nazarian as its new executive…
